bpc-157 fda warning letter compounding FDA issued 25 warning letters
Description
Subcutaneous injection provides systemic bioavailability for joint, tendon, muscle, and broader tissue repair indications, complementing the gut-specific action of oral BPC-157
Instead, it prevents them from reproducing
The upper arm will be cleaned and prepared and a small needle will be used to administer the B12 intramuscularly
Discard after 2030 days
